ecancermedicalscience

Review

Metastasis-directed therapy for oligometastatic urological tumours: still no second-hand news

7 May 2020
Charlien Berghen, Steven Joniau, Christof Vulsteke, Maarten Albersen, Gaëtan Devos, Kato Rans, Karin Haustermans, Gert De Meerleer

For patients presenting with limited metastatic disease burden, known as the oligometastatic state of disease, a more aggressive treatment approach targeting the new or progressive metastatic lesions might improve patient outcome, with no or only limited toxicity to be expected from the treatment. This review provides an overview of the existing evidence and on-going trials on oligometastatic disease and metastasis-directed therapy in the field of renal, bladder and prostate cancer.

Related Articles

Ranti Ghosh, Debarshi Lahiri, Debjit Ghosh, Kushal Sen, Debanjan Chakraborty, Tapas Maji, Suparna Mazumder, Ranajit Mandal, Arit Bhattacharjee, Jayanta Chakrabarti
Bartholomeo Nicholaus Ngowi, Alex Mremi, Mshangama Seif, Frank Bright, Godrule Lyimo, Innocent Uggh, Modesta Paschal Mitao, Obadia Nyongole, Orgeness Jasper Mbwambo, Harcharan Gill, Mramba Nyindo, Kien Alfred Mteta, Blandina Theophil Mmbaga
Shubham Dokania, Ajay K Choubey, Shashank Tiwari, Prasenjit Nath, Jhansi Pattanaik, Sambit S Nanda, Ashutosh Mukherji, Satyajit Pradhan
Ahmed A Hammad, Osama Ezzat, Alex Filicevas, Sara A Hammad, Mostafa M Elkady, Mohamed E Eladl, Karim Mosaad, Mohammed M Shalaby, Ahmed A Barakat, Karim Y El-Deeb, Basma A Eldawody, Ghada Elkanishy, Muhammed A Moukhtar Hammad, Ahmed Mosbah
Anass Baladi, Hassan Abdelilah Tafenzi, Fatim-Zahra Megzar, Ibrahima Kalil Cisse, Othmane Zouiten, Leila Afani, Ismail Essaadi, Mohammed El Fadli, Rhizlane Belbaraka